Renegade Bio

Renegade Bio

Renegade Bio is a medical diagnostics company based in San Francisco founded in 2020 by Craig Rouskey.

Renegade Bio is a medical diagnostics, SOSV backed, IndieBio startup. The company is a B Corporation, with the highest standards of social and environmental performance, public transparency and legal accountability.

Renegade Bio improved on the CDC PCR-based diagnostic testing method for COVID-19 by reducing four reactions to a single step that eliminates the need for the RNA extraction step. The test is claimed to cost 70% less and take half the time to complete. Renegade partnered with the Bay Area Phlebotomy and Laboratory Services with the aim to allow open public testing on-demand as an Uber-like service. The company is beginning by testing San Francisco Bay Area first responders and police forces and is running 1300 tests every three days.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Convertible Note
February 1, 2018
SOSV
Debt Financing
914,359
April 21, 2016
SOSV
Renegade Bio Seed round, March 2020
Seed round
800,000
March 18, 2020
Renegade Bio Seed round, April 2020
Seed round
334,000
April 21, 2020
SOSV
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Craig Rouskey

CSO, Co-Founder

Gabriel Paulino

CEO, Co-Founder

Julia Russotti

CFO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.